Chronotherapeutic diltiazem formulations and the...

Details Chronotherapeutic diltiazem formulations and the... Chronotherapeutic diltiazem formulations and the...

2008-03-25

2008-03-25

Sheikh, Humera N (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Particulate form

C424S490000, C424S464000, C424S468000

Reexamination Certificate

active

10657752

ABSTRACT:
A method of treating or preventing myocardial ischemia in a patient in need thereof comprising administration of a controlled-release Galenical preparation of pharmaceutically acceptable Diltiazem including the pharmaceutically acceptable salts thereof, suitable for evening dosing every 24 hours containing from about 180 mg to about 420 mg of the form of Diltiazem associated with excipients to provide controlled (sustained) release of the form of Diltiazem for providing a Cmaxof Diltiazem in the blood at between about 10 hours and about 17 hours after administration, the preparation comprising the form of Diltiazem in oral sustained-release dosage form in which the Diltiazem is adapted to be released after administration over a prolonged period of time and exhibits when given to humans(i) a higher bioavailability when given at night compared to when given in the morning without food according to FDA guidelines or criteria and(ii) bioequivalence when given in the morning with and without food according to the same FDA guidelines or criteria.

REFERENCES:
patent: 4721619 (1988-01-01), Panoz et al.
patent: 4960596 (1990-10-01), Debregeas et al.
patent: 5229135 (1993-07-01), Philippon et al.
patent: 5288505 (1994-02-01), Deboeck et al.
patent: 5344657 (1994-09-01), Desmolin
patent: 5529790 (1996-06-01), Eichel et al.
patent: 5616345 (1997-04-01), Geoghegan et al.
patent: 6524620 (2003-02-01), Chen et al.
patent: 7108866 (2006-09-01), Albert et al.
patent: WO 01/41744 (2001-06-01), None

Affiliated with

Also associated with

Rating

Chronotherapeutic diltiazem formulations and the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chronotherapeutic diltiazem formulations and the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chronotherapeutic diltiazem formulations and the... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3912282